Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity

Table 2

Classification of ROP in the eyes treated with intravitreal injections of bevacizumab.

ROP classification	Eyes (number)	Eyes (%)
AP-ROP	52	70.27
Stage 3 zone I with “plus”	22	29.72

AP-ROP = aggressive posterior ROP.